Life Lab Science Program
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,001,516
Cash & Equivalents
41%
Receivables (Non-Related)
38%
Other Assets
14%
Property, Plant, & Equipment (net)
7%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Liabilities in 2024 (Year End)
$595,449
Other Liabilities
49%
Notes Payable / Debt (Non-Related)
28%
Payables & Accruals
13%
Deferred Revenue
10%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$440,613
$414,240
-6%
Receivables (Non-Related)
$698,790
$379,514
-46%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$16,083
$0
-100%
Investments
$0
$0
-
Property, Plant, & Equipment (net)
$80,813
$71,726
-11%
Other Assets
$133,604
$136,036
+2%
Total Assets
$1,369,903
$1,001,516
-27%
Liabilities
2023
2024
Change
Payables & Accruals
$37,391
$75,453
+102%
Grants Payable
-
-
-
Deferred Revenue
$631,328
$60,000
-90%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
$169,700
-
Related-Party Payables
-
-
-
Other Liabilities
$273,467
$290,296
+6%
Total Liabilities
$942,186
$595,449
-37%
Net assets
2023
2024
Change
Restricted Net Assets
$1,026,190
$590,454
-42%
Unrestricted Net Assets
-$598,473
-$184,387
+69%
Net assets
2023
2024
Change
Net assets
+$427,717
+$406,067
-5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)